Clinical Trial Update: Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease [Phase 4]

View source ↗

Summary

A Phase 4 pilot study evaluating intravenous ketamine for acute pain crises in patients with sickle cell disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Sickle Cell Disease | Phase 4 | Status: TERMINATED